The medication contains human chorionic gonadotropin (hCG), a hormone that mimics the action of luteinizing hormone. In women, it triggers final follicular maturation and ovulation, while in men it stimulates Leydig cells to promote testosterone production and support spermatogenesis.
Recommended for:
– women with anovulatory infertility
– assisted reproductive technology and IVF protocols
– men with hypogonadotropic hypogonadism
– hormone-related male infertility
The clinical effectiveness of hCG is supported by long-term use in reproductive medicine and extensive clinical research. It is a standard component of international fertility treatment guidelines.
Indicated for ovulation induction in women, luteal phase support, and treatment of hormone-related infertility in men. The drug acts by activating luteinizing hormone receptors to restore normal reproductive function.
The medication is administered by intramuscular or subcutaneous injection after reconstitution of the lyophilized powder. Dosage and treatment regimen are determined individually by a healthcare professional based on the therapeutic protocol.
Contraindications
– hypersensitivity to human chorionic gonadotropin
– hormone-dependent tumors
– thromboembolic disorders
– pituitary or hypothalamic tumors
– polycystic ovary syndrome with risk of ovarian hyperstimulation
– pregnancy except when specifically indicated
Side effects
– injection site pain
– headache
– irritability
– fluid retention
– ovarian hyperstimulation syndrome
– gynecomastia in men
